Daiichi Life Insurance Co. Ltd. Takes Position in Xylem Inc. $XYL

Daiichi Life Insurance Co. Ltd. bought a new stake in Xylem Inc. (NYSE:XYL) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 12,275 shares of the industrial products company’s stock, valued at approximately $1,451,000.

A number of other institutional investors have also made changes to their positions in the stock. Orion Porfolio Solutions LLC increased its stake in shares of Xylem by 1.0% in the 3rd quarter. Orion Porfolio Solutions LLC now owns 7,802 shares of the industrial products company’s stock valued at $1,151,000 after acquiring an additional 74 shares during the last quarter. Quest Investment Management LLC boosted its stake in Xylem by 1.0% during the 3rd quarter. Quest Investment Management LLC now owns 7,588 shares of the industrial products company’s stock worth $1,119,000 after acquiring an additional 77 shares during the last quarter. Notis McConarty Edward grew its holdings in Xylem by 0.3% during the fourth quarter. Notis McConarty Edward now owns 31,678 shares of the industrial products company’s stock valued at $4,314,000 after purchasing an additional 86 shares during the period. Moneco Advisors LLC grew its holdings in Xylem by 4.6% during the fourth quarter. Moneco Advisors LLC now owns 2,049 shares of the industrial products company’s stock valued at $279,000 after purchasing an additional 90 shares during the period. Finally, Compound Planning Inc. increased its stake in Xylem by 4.2% in the fourth quarter. Compound Planning Inc. now owns 2,258 shares of the industrial products company’s stock valued at $308,000 after purchasing an additional 91 shares in the last quarter. 87.96% of the stock is owned by institutional investors and hedge funds.

Xylem Trading Up 0.2%

Shares of Xylem stock opened at $113.62 on Monday. The firm has a 50-day moving average of $118.04 and a 200-day moving average of $119.67. The stock has a market cap of $26.53 billion, a PE ratio of 27.05, a PEG ratio of 1.57 and a beta of 1.02. Xylem Inc. has a 52-week low of $105.29 and a 52-week high of $154.27. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.24 and a current ratio of 1.61.

Xylem (NYSE:XYL) last released its quarterly earnings results on Tuesday, July 28th. The industrial products company reported $1.46 EPS for the quarter, beating the consensus estimate of $1.34 by $0.12. Xylem had a net margin of 11.15% and a return on equity of 11.77%. The business had revenue of $2.34 billion for the quarter, compared to the consensus estimate of $2.34 billion. During the same period in the prior year, the company posted $1.26 earnings per share. Xylem’s revenue was up 1.5% compared to the same quarter last year. Xylem has set its FY 2026 guidance at 5.550-5.700 EPS. As a group, sell-side analysts forecast that Xylem Inc. will post 5.67 EPS for the current year.

Xylem Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 24th. Shareholders of record on Thursday, August 27th will be given a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.5%. The ex-dividend date is Thursday, August 27th. Xylem’s dividend payout ratio is presently 40.95%.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on XYL. Mizuho boosted their price objective on Xylem from $124.00 to $130.00 and gave the company a “neutral” rating in a research report on Wednesday, July 29th. Weiss Ratings restated a “hold (c)” rating on shares of Xylem in a research note on Wednesday, August 5th. Stifel Nicolaus increased their price target on shares of Xylem from $157.00 to $160.00 and gave the company a “buy” rating in a report on Wednesday, July 29th. Oppenheimer cut their price objective on shares of Xylem from $160.00 to $158.00 and set an “outperform” rating for the company in a research report on Wednesday, April 29th. Finally, UBS Group boosted their price objective on Xylem from $135.00 to $138.00 and gave the stock a “neutral” rating in a report on Thursday, August 13th. Nine analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $154.23.

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.